Page 74 - Genentech News Today

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to provide key highlights of the clinical...

​​​​​​​Genentech, Roche, and Biogen filed a Complaint on November 17 against Dr. Reddy’s Laboratories (“DRL”) and Fresenius in the U.S. District Court for the District of New Jersey,...

Nvidia said its offerings will accelerate the training and inference of generative models used in Genentech’s “lab in the loop” framework, where extensive experimental data is fed into models for iterative drug discovery.

By Nina Kienle Roche Holdings Genentech and U.S. chip giant Nvidia have entered into a multiyear artificial-intelligence research collaboration to accelerate drug discovery and development....

BioPharma

Maybe one of your patients can join a new clinical trial in noncolorectal gastrointestinal cancer?

The acceleration of Genentech’s machine learning (ML) capabilities will take place on Nvidia’s DGX Cloud. This includes Nvidia BioNemo, which uses generative AI applications in drug discovery.

Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with others, there are several emerging key players, that are...

Record revenue of $18.12 billion, up 34% from Q2, up 206% from year agoRecord Data Center revenue of $14.51 billion, up 41% from Q2, up 279% from year ago ...

Reduced demand and revenue for the jabs isn’t bad news. The industry is working as it’s designed.